SHARON LONG: Open Payments
NPI 1568440725 · WASHINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 11 payments from 10 companies in 2025. Trend: 2023 $1,095 · 2024 $1,603 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $195 |
| Averitas Pharma Inc. | 1 | $145 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
| Axsome Therapeutics, Inc. | 1 | $102 |
| Eisai Inc. | 1 | $94 |
| COLOPLAST CORP | 1 | $44 |
Products named: QUTENZA, PYRUKYND, Wegovy, REXULTI, WAINUA, SPRAVATO, Auvelity, Leqembi.
Industry payments across MI — which companies pay providers there.
